近日,广东永青生物科技有限公司与广东农垦华海糖业发展有限公司合作采用甘蔗原料生产结晶果糖项目,通过了国家加工食品质量监督检验中心的测试检验,成为我国目前唯一一家采用甘蔗原料的规模化大产能非转基因结晶果糖生产企业。结晶果糖是一种功能性糖类,可以精制成医用果糖注射液,适用于糖尿病人及肝功能不全的患者,以前国内只有采用玉米淀粉等转化而成的结晶果糖。该项技术的问世,不仅填补了国内空白,而且对延伸甘蔗产业 Recently, Guangdong Yongqing Biotechnology Co., Ltd. and Guangdong Land Reclamation Huarui Sugar Development Co., Ltd. to use sugar cane raw materials to produce crystalline fructose project, passed the State Processed Food Quality Supervision and Inspection Center test, as China’s only one using sugar cane raw materials scale Large-capacity non-genetically modified fructose crystal production enterprises. Crystalline fructose is a functional saccharide, can be refined into medical fructose injection for patients with diabetes and liver dysfunction, previously only the use of corn starch and other transformed into crystalline fructose. The advent of this technology, not only to fill gaps in the domestic, but also to extend the sugar cane industry